Skip to main content
SpringerLink
Log in
Book cover

Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS pp 767–775Cite as

Renal Insufficiency

  • Chapter

  • 299 Accesses

Abstract

Regardless of the primary etiology of renal disease, the progressive decline in renal function eventually leads to uremia. In most patients with chronic renal insufficiency the signs and symptoms of uremia manifest when glomerular filtration rate (GFR) decreases to less than 15–20mL/min. When GFR reaches a level lower than 5 mL/min, end-stage renal disease sets in and replacement therapy in the form of dialysis or transplantation becomes unavoidable. This chapter focuses on the conservative management of patients with chronic renal insufficiency who do not yet require renal replacement therapy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hebert LA, Bay WH: On the natural tendency to progressive loss of remaining kidney function in patients with impaired renal function. Med Clin North Am 74: 1011–1024, 1990.

    PubMed  CAS  Google Scholar 

  2. Martinez-Maldonado M, Benabe JE, Cordova HR: Chronic clinical intrinsic renal failure. In: DW Seldin, G Giebisch, eds, The Kidney: Physiology and Pathophysiology, 2nd ed. Raven Press, New York, 1992.

    Google Scholar 

  3. Jacobson H: Chronic renal failure: pathophysiology. Lancet 338: 419–423, 1991.

    Article  PubMed  CAS  Google Scholar 

  4. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118: 129–138, 1993.

    Article  PubMed  CAS  Google Scholar 

  5. Tolins JP, Raij L: Antihypertensive therapy and the progression of chronic renal disease. Are there renoprotective drugs? Semin Nephrol 11: 538–548, 1991.

    PubMed  CAS  Google Scholar 

  6. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380, 1982.

    Article  PubMed  CAS  Google Scholar 

  7. Keane WF, Anderson S, Aurell M, de Zeeuw D, Narins RG, Povar G: Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions. Ann Intern Med 111: 503–516, 1989.

    Article  PubMed  CAS  Google Scholar 

  8. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456–1462, 1993.

    Article  PubMed  Google Scholar 

  9. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in mormotensive type II diabetic patients. Ann Intern Med 118: 577–581, 1993.

    Article  PubMed  CAS  Google Scholar 

  10. Kaplan NM: Renal parenchymal hypertension. In: Clinical Hypertension, 5th ed. Williams and Wilkins, Baltimore, 1990.

    Google Scholar 

  11. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G, for the Modification of Diet in Renal Disease study group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330: 877–884, 1994.

    Article  PubMed  Google Scholar 

  12. Mitch WE: Dietary protein restriction in patients with chronic renal failure. Kidney Int 40: 326–341, 1991.

    Article  PubMed  CAS  Google Scholar 

  13. Lau K: Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis. Kidney Int 36: 918–937, 1989.

    Article  PubMed  CAS  Google Scholar 

  14. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384–394, 1990.

    Article  PubMed  CAS  Google Scholar 

  15. Praga M, Hernandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL: Long-term beneficial effects of angiotensinconverting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20: 240–248, 1992.

    PubMed  CAS  Google Scholar 

  16. Grundy SM: Management of hyperlipidemia of kidney disease. Kidney Int 37: 847–853, 1990.

    Article  PubMed  CAS  Google Scholar 

  17. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O’Donnell MP: Hyperlipidemia and progressive renal disease. Kidney Int 39: S41–48, 1991.

    Google Scholar 

  18. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor ß or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92: 2597–2601, 1993.

    Article  PubMed  CAS  Google Scholar 

  19. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor ßl. Nature 346: 371–374, 1990.

    Article  PubMed  CAS  Google Scholar 

  20. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor ß protects against scarring in experimental kidney disease. Nature 360: 361–364, 1992.

    Article  PubMed  CAS  Google Scholar 

  21. Tang WW, Feng L, Vannice JL, Wilson CB: Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. J Clin Invest 93: 273–279, 1994.

    Article  PubMed  CAS  Google Scholar 

  22. Woo DDL, Miao SYP, Pelayo JC, Woolf AS: Taxol inhibits progression of congenital polycystic kidney disease. Nature 368: 750–753, 1994.

    Article  PubMed  CAS  Google Scholar 

  23. Kaloyanides GJ: Aminoglycoside nephrotoxicity. In: RW Schrier, CW Gottschalk, eds, Diseases of the Kidney, vol 2, 5th ed. Little, Brown, Boston, 1993.

    Google Scholar 

  24. Levison ME: New dosing regimens for aminoglycoside antibiotics. Ann Intern Med 117: 693–694, 1992.

    Article  PubMed  CAS  Google Scholar 

  25. Schlondorff D: Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int 44: 643–653, 1993.

    Article  PubMed  CAS  Google Scholar 

  26. Whelton A, Stout RL, Spilman PS, Klassen DK: Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. Ann Intern Med 112: 568–576.

    Google Scholar 

  27. Clive DM, Stoff JS: Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310: 563–572, 1984.

    Article  PubMed  CAS  Google Scholar 

  28. Ten RM, Torres VE, Milliner DS, Schwab TR, Holley KE, Gleich GJ: Acute interstitial nephritis: immunologic and clinical aspects. Mayo Clin Proc 63: 921–930, 1988.

    Article  PubMed  CAS  Google Scholar 

  29. Galpin JE, Shinaberger JH, Stanley TM, Blumenkrantz MJ, Bayer AS, Friedman GS, Montgomerie JZ, Guze LB, Coburn JW, Glassock RJ: Acute interstitial nephritis due to methicillin. Am J Med 65: 756–765, 1978.

    Article  PubMed  CAS  Google Scholar 

  30. Bennet WM, Aronoff GR, Golper TA, Morrison G, Singer I, Brater DC: Drug Prescribing in Renal Failure. Dosing Guidelines for Adults, 2nd ed. American College of Physicians, Philadelphia, 1991.

    Google Scholar 

  31. Berns AS: Nephrotoxicity of contrast media. Kidney Im 36: 730–740, 1989.

    Article  CAS  Google Scholar 

  32. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, Bashore TM: Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320: 149–153, 1989.

    Article  PubMed  CAS  Google Scholar 

  33. Cigarroa RG, Lange RA, Williams RH, Hillis LD: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86: 649–652, 1989.

    Article  PubMed  CAS  Google Scholar 

  34. Coburn JW, Agre KL: Renal thromboembolism, atheroembolism, and other acute diseases of the renal arteries. In: RW Schrier, CW Gottschalk, eds, Diseases of the Kidney, vol 2, 5th ed. Little, Brown, Boston, 1993.

    Google Scholar 

  35. Hou SH, Grossman SD, Madias NE: Pregnancy in women with renal disease and moderate renal insufficiency. Am J Med 78: 185–194, 1985.

    Article  PubMed  CAS  Google Scholar 

  36. Surian M, Imbasciati E, Cosci P, et al.: Glomerular disease and pregnancy. A study of 123 pregnancies in patients with primary and secondary glomerular diseases. Nephron 36: 10 1105, 1984.

    Google Scholar 

  37. Rose BD: Diuretics. Kidney Int 39: 336–352, 1991.

    Article  PubMed  CAS  Google Scholar 

  38. Warnock DG: Uremic acidosis. Kidney Int 34: 278–287, 1988.

    Article  PubMed  CAS  Google Scholar 

  39. Ypersele De Strihou CVY: Potassium homeostasis in renal failure. Kidney Int 11: 491–504, 1977.

    Article  Google Scholar 

  40. Delmez JA, Slatopolsky E: Recent advances in the pathogenesis and therapy of uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 72: 735–739, 1991.

    Article  PubMed  CAS  Google Scholar 

  41. Malluche H, Faugere MC: Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 38: 193–211, 1990.

    Article  PubMed  CAS  Google Scholar 

  42. De Fronzo RA, Tobin JD, Rowe JW, et al.: Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 62: 425–435, 1978.

    Article  Google Scholar 

  43. Kaptein EM, Quion-Verde H, Choolzian CJ, et al.: The thyroid in end-stage renal disease. Medicine (Baltimore) 67: 187197, 1988.

    Google Scholar 

  44. Schaefer F, Ritz E, Kokot F, Massry SG: Metabolic and endocrine dysfunctions in uremia. In: RW Schrier, CW Gottschalk, eds, Diseases of the Kidney, vol 3, 5th ed. Little, Brown, Boston, 1993.

    Google Scholar 

  45. Paganini EP, Rothmann SA, Paul P, Meagher RC: Hematologic abnormalities. In: JT Daugirdas, TS Ing, eds, Handbook of Dialysis, 1st ed. Little, Brown, Boston, 1988.

    Google Scholar 

  46. Lundin AP: Recombinant erythropoietin and chronic renal failure. Hosp Pract 26 (4): 61–69, 1991.

    CAS  Google Scholar 

  47. Abels R: Rate of progression of chronic renal failure in predialysis patients treated with erythropoietin. Semin Nephrol 10 (Suppl 1): 20–25, 1990.

    PubMed  CAS  Google Scholar 

  48. Lim VS, DeGowin RL, Zavala D, Kirchner PT, Abels R, Perry P, Fangman J: Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial. Ann Intern Med 110: 108–114, 1989.

    Article  PubMed  CAS  Google Scholar 

  49. Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS: Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308: 8–12, 1983.

    Article  PubMed  CAS  Google Scholar 

  50. Centers for Disease Control: General recommendations on immunization. Guidelines from the immunization practices advisory committee. Ann Intern Med 111: 133–142, 1989.

    Article  Google Scholar 

  51. Bolton CF, Baltzan MA, Baltzan RB: Effects of renal transplantation on uremic neuropathy. N Engl J Med 284: 1170, 1971.

    Article  PubMed  CAS  Google Scholar 

  52. Burt RK, Gupta-Burt S, Suki WN, Barcenas CG, Ferguson JJ, Van Buren CT: Reversal of left ventricular dysfunction after renal transplantation. Ann Intern Med 111: 635–640, 1989.

    Article  PubMed  CAS  Google Scholar 

  53. Balaskas EV, Oreopoulos DG: Uremic pruritus. Dial Transplant 21: 278–284, 1992.

    Google Scholar 

  54. Bay WH, Hebert LA: The living donor in kidney transplantation. Ann Intern Med 106: 719–727, 1987.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nephrology Division Department of Medicine, Atlanta Department of Veterans Affairs Medical Center, Emory University School of Medicine and The Medical and Research Services, Decatur, GA, 30033, USA

    Fadi G. Lakkis M.D.

  2. Medical Service, Atlanta Department of Veterans Affairs Medical Center, Emory University School of Medicine and The Medical and Research Services, Decatur, DC, 30033, USA

    Manuel Martinez-Maldonado M.D. (Professor and Vice Chairman, Chief)

Authors
  1. Fadi G. Lakkis M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manuel Martinez-Maldonado M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Wadi N. Suki M.D. Shaul G. Massry M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lakkis, F.G., Martinez-Maldonado, M. (1998). Renal Insufficiency. In: Suki, W.N., Massry, S.G. (eds) Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6632-5_46

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6632-5_46

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6634-9

  • Online ISBN: 978-1-4757-6632-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation